163 related articles for article (PubMed ID: 9751109)
1. Avocado/soybean unsaponifiables in the treatment of scleroderma: comment on the article by Maheu et al.
Jablonska S
Arthritis Rheum; 1998 Sep; 41(9):1705. PubMed ID: 9751109
[No Abstract] [Full Text] [Related]
2. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
3. [Histomorphologic and histochemical changes in the skin during the treatment of scleroderma].
Sych LI; Trofimova LIa
Vestn Dermatol Venerol; 1971; 45(3):22-6. PubMed ID: 5122538
[No Abstract] [Full Text] [Related]
4. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
5. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
6. Morphometric analysis of human gingival elastic fibres degradation by human leukocyte elastase protective effect of avocado and soybean unsaponifiables (ASU).
Kut C; Assoumou A; Dridi M; Bonnefoix M; Gogly B; Pellat B; Guillou GB; Godeau G
Pathol Biol (Paris); 1998 Sep; 46(7):571-6. PubMed ID: 9842576
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of generalized scleroderma with connective tissue inhibitors].
Asboe-Hansen G
Ugeskr Laeger; 1976 May; 138(22):1325-9. PubMed ID: 1273949
[No Abstract] [Full Text] [Related]
8. [Observations of the course of scleroderma after combined Hylase-carnitine therapy].
Nitzschner H
Z Arztl Fortbild (Jena); 1975 Nov; 69(21):1108. PubMed ID: 1226844
[No Abstract] [Full Text] [Related]
9. ["Antisclerotic" therapy of scleroderma: insaponifiable oils of avocado and soya. 50 clinical applications of H. Thiers treatment].
Lamberton JN
Presse Med (1893); 1970 May; 78(27):1235-6. PubMed ID: 5463415
[No Abstract] [Full Text] [Related]
10. [Treatment of circumscribed scleroderma in childhood].
Nagy E; Ladányi E
Z Hautkr; 1987 Apr; 62(7):547-9. PubMed ID: 3590919
[TBL] [Abstract][Full Text] [Related]
11. Treatment of localized scleroderma in childhood: Comment on the article by Zulian et al.
Kreuter A; Altmeyer P; Gambichler T
Arthritis Rheum; 2006 Sep; 54(9):3065-6; author reply 3066. PubMed ID: 16948151
[No Abstract] [Full Text] [Related]
12. Photochemotherapy for systemic and localized scleroderma.
De Rie MA; Bos JD
J Am Acad Dermatol; 2000 Oct; 43(4):725-6. PubMed ID: 11004642
[No Abstract] [Full Text] [Related]
13. [Corticostesteroids in the treatment of scleroderma].
Szczepański A
Przegl Dermatol; 1971; 58(6):749-53. PubMed ID: 5139315
[No Abstract] [Full Text] [Related]
14. [Treatment of scleroderma with depolymerizing agents].
Konopík J; Krs V
Cas Lek Cesk; 1982 Nov; 121(44):1368-72. PubMed ID: 7172189
[No Abstract] [Full Text] [Related]
15. Avocado/soybean unsaponifiables, ASU EXPANSCIENCE, are strictly different from the nutraceutical products claiming ASU appellation.
Msika P; Baudouin C; Saunois A; Bauer T
Osteoarthritis Cartilage; 2008 Oct; 16(10):1275-6. PubMed ID: 18420430
[No Abstract] [Full Text] [Related]
16. [Treatment of some sclerosing processes with uropancreozymin].
Hodác V; Svatos A
Cesk Dermatol; 1971 Apr; 46(2):83-6. PubMed ID: 5564727
[No Abstract] [Full Text] [Related]
17. [Proteolytic enzyme, trypsin, in therapy of patients with scleroderma].
Dovzhanskiĭ SI; Slesarenko NA
Vestn Dermatol Venerol; 1977 Aug; (8):56-8. PubMed ID: 930311
[No Abstract] [Full Text] [Related]
18. [Treatment of systemic scleroderma with piascledine].
Petrova IL; Shakhnes IE
Vestn Dermatol Venerol; 1979 Oct; (10):46-8. PubMed ID: 574343
[No Abstract] [Full Text] [Related]
19. [Treatment of hypodermatitis of the leg with unsaponifiable extracts of avocado and soya].
Chaze J
Phlebologie; 1972; 25(3):315-8. PubMed ID: 4662060
[No Abstract] [Full Text] [Related]
20. [Avocado/soybean unsaponifiables in the treatment of knee and hip osteoarthritis].
Angermann P
Ugeskr Laeger; 2005 Aug; 167(33):3023-5. PubMed ID: 16109242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
